Cash Flow Statement
Growth Metrics

Mimedx (MDXG) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -13.32%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 17.12%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -10.19%
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 24.11%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 12.18%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 3.92%
10 Mimedx 530.69 Mn 370.92 Mn 41.62 Mn -17.62%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -17.62%
Dec 31, 2025 -20.71%
Sep 30, 2025 -22.45%
Jun 30, 2025 -20.99%
Mar 31, 2025 -21.35%
Dec 31, 2024 -14.77%
Sep 30, 2024 -9.06%
Jun 30, 2024 -6.05%
Mar 31, 2024 -2.94%
Dec 31, 2023 -11.23%
Sep 30, 2023 -10.34%
Jun 30, 2023 -12.81%
Mar 31, 2023 -13.67%
Dec 31, 2022 -14.28%
Sep 30, 2022 -19.72%
Jun 30, 2022 -18.93%
Mar 31, 2022 -20.69%
Dec 31, 2021 -19.87%
Sep 30, 2021 -3.89%
Jun 30, 2021 -5.06%
Mar 31, 2021 -6.67%
Dec 31, 2020 -7.23%
Sep 30, 2020 -22.19%
Jun 30, 2020 -26.25%
Mar 31, 2020 -27.75%
Dec 31, 2019 -29.25%
Dec 31, 2018 23.65%
Dec 31, 2017 0.76%
Sep 30, 2017 -3.58%
Jun 30, 2017 10.50%
Mar 31, 2017 13.53%
Dec 31, 2016 47.60%
Sep 30, 2016 64.24%
Jun 30, 2016 81.64%
Mar 31, 2016 88.25%
Dec 31, 2015 73.95%
Sep 30, 2015 65.79%
Jun 30, 2015 53.49%
Mar 31, 2015 50.16%
Dec 31, 2014 33.31%
Sep 30, 2014 34.31%
Jun 30, 2014 56.50%
Mar 31, 2014 271.75%
Dec 31, 2013 281.29%
Sep 30, 2013 276.21%
Jun 30, 2013 215.24%
Mar 31, 2013 43.17%
Dec 31, 2012 23.26%
Sep 30, 2012 9.05%
Jun 30, 2012 27.97%
Dec 31, 2011 14.86%